Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03050086 · ClinicalTrials.gov registry record · Phase 1
Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea
A Phase 1 study, sponsored by BioPharmX.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT03050086 is a Phase 1 study that has completed, run by BioPharmX. The registered enrollment target is 30 participants.
The verdict
NCT03050086, a Phase 1 study, has completed, sponsored by BioPharmX.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
An open label feasibility study using BPX-04 topical minocycline gel in papulopustular rosacea.
Interventions
- DRUG BPX-04 1% minocycline topical gel
- DRUG BPX-04 2% minocycline topical gel
- DRUG BPX-04 vehicle topical gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2018-06-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03050086
The ClinicalTrials.gov registry entry for NCT03050086 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioPharmX, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BPX-04 1% minocycline topical gel is the first listed.
NCT03050086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03050086 about?
NCT03050086 is a clinical study titled "Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea". An open label feasibility study using BPX-04 topical minocycline gel in papulopustular rosacea.
What is the current status of trial NCT03050086?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2017-03-29. Estimated completion is 2018-06-19.
What interventions are being tested in trial NCT03050086?
The interventions under investigation include: BPX-04 1% minocycline topical gel (DRUG), BPX-04 2% minocycline topical gel (DRUG), BPX-04 vehicle topical gel (DRUG).
Who is sponsoring clinical trial NCT03050086?
This trial is sponsored by BioPharmX, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.